1-14 of 14
Robert E. Coleman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)

John F.R. Robertson, Robert E. Coleman, Kwok-Leung Cheung, Abigail Evans, Chris Holcombe, Anthony Skene, Daniel Rea, Samreen Ahmed, Ali Jahan, Kieran Horgan, Petra Rauchhaus, Roberta Littleford, S.Y. Amy Cheung, Marie Cullberg, Elza C. de Bruin, Loumpiana Koulai, Justin P.O. Lindemann, Martin Pass, Paul Rugman, Gaia Schiavon, Rahul Deb, Pauline Finlay, Andrew Foxley, Julia M.W. Gee
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (24): 5469.
https://doi.org/10.1158/1078-0432.CCR-22-3568
Published: 15 December 2022
View article titled, Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER<sup>+</sup> Invasive Breast Cancer (STAKT)
Open the PDF for Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER<sup>+</sup> Invasive Breast Cancer (STAKT) in another window
Journal Articles

Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)

John F.R. Robertson, Robert E. Coleman, Kwok-Leung Cheung, Abigail Evans, Chris Holcombe, Anthony Skene, Daniel Rea, Samreen Ahmed, Ali Jahan, Kieran Horgan, Petra Rauchhaus, Roberta Littleford, S.Y. Amy Cheung, Marie Cullberg, Elza C. de Bruin, Loumpiana Koulai, Justin P.O. Lindemann, Martin Pass, Paul Rugman, Gaia Schiavon, Rahul Deb, Pauline Finlay, Andrew Foxley, Julia M.W. Gee
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (7): 1574–1585.
https://doi.org/10.1158/1078-0432.CCR-19-3053
Published: 01 April 2020
View article titled, Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER<sup>+</sup> Invasive Breast Cancer (STAKT)
Open the PDF for Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER<sup>+</sup> Invasive Breast Cancer (STAKT) in another window
Includes: Supplementary data
Journal Articles

Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment

Claudia Tulotta, Diane V. Lefley, Katy Freeman, Walter M. Gregory, Andrew M. Hanby, Paul R. Heath, Faith Nutter, J. Mark Wilkinson, Amy R. Spicer-Hadlington, Xinming Liu, Steven M.J. Bradbury, Lisa Hambley, Victoria Cookson, Gloria Allocca, Marianna Kruithof de Julio, Robert E. Coleman, Janet E. Brown, Ingunn Holen, Penelope D. Ottewell
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (9): 2769–2782.
https://doi.org/10.1158/1078-0432.CCR-18-2202
Published: 01 May 2019
View article titled, Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
Open the PDF for Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant Chemotherapy with or without Zoledronic Acid in Early Breast Cancer—A Randomized Biomarker Pilot Study

Matthew C. Winter, Caroline Wilson, Stuart P. Syddall, Simon S. Cross, Alyson Evans, Christine E. Ingram, Ingrid J. Jolley, Matthew Q. Hatton, Jennifer V. Freeman, Stefano Mori, Ingunn Holen, Robert E. Coleman
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (10): 2755–2765.
https://doi.org/10.1158/1078-0432.CCR-12-3235
Published: 12 May 2013
View article titled, Neoadjuvant Chemotherapy with or without Zoledronic Acid in Early Breast Cancer—A Randomized Biomarker Pilot Study
Open the PDF for Neoadjuvant Chemotherapy with or without Zoledronic Acid in Early Breast Cancer—A Randomized Biomarker Pilot Study in another window
Journal Articles

Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients

Janet E. Brown, Richard J. Cook, Allan Lipton, Robert E. Coleman
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6348–6355.
https://doi.org/10.1158/1078-0432.CCR-12-1397
Published: 14 November 2012
View article titled, Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients
Open the PDF for Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients in another window
Journal Articles

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

Allan Lipton, Guenther G. Steger, Jazmin Figueroa, Cristina Alvarado, Philippe Solal-Celigny, Jean Jacques Body, Richard de Boer, Rossana Berardi, Pere Gascon, Katia S. Tonkin, Robert E. Coleman, Alexander H.G. Paterson, Guozhi M. Gao, Amy C. Kinsey, Mark C. Peterson, Susie Jun
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6690–6696.
https://doi.org/10.1158/1078-0432.CCR-07-5234
Published: 16 October 2008
View article titled, Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy
Open the PDF for Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy in another window
Journal Articles

Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference

Robert E. Coleman, Theresa A. Guise, Allan Lipton, G. David Roodman, James R. Berenson, Jean-Jacques Body, Brendan F. Boyce, Laura M. Calvi, Peyman Hadji, Eugene V. McCloskey, Fred Saad, Matthew R. Smith, Larry J. Suva, Russell S. Taichman, Robert L. Vessella, Katherine N. Weilbaecher
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6387–6395.
https://doi.org/10.1158/1078-0432.CCR-08-1572
Published: 16 October 2008
View article titled, Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference
Open the PDF for Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference in another window
Journal Articles

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

James E. Lester, David Dodwell, Omprakash P. Purohit, Sandra A. Gutcher, Susan P. Ellis, Ruth Thorpe, Janet M. Horsman, Janet E. Brown, Rosemary A. Hannon, Robert E. Coleman
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19): 6336–6342.
https://doi.org/10.1158/1078-0432.CCR-07-5101
Published: 30 September 2008
View article titled, Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
Open the PDF for Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer in another window
Journal Articles

Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo

Penelope D. Ottewell, Blandine Deux, Hannu Mönkkönen, Simon Cross, Robert E. Coleman, Philippe Clezardin, Ingunn Holen
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4658–4666.
https://doi.org/10.1158/1078-0432.CCR-07-1545
Published: 15 July 2008
View article titled, Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth <em>In vivo</em>
Open the PDF for Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth <em>In vivo</em> in another window
Journal Articles

Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid

Janet E. Brown, Susan P. Ellis, James E. Lester, Sandra Gutcher, Tina Khanna, Om-Prakesh Purohit, Eugene McCloskey, Robert E. Coleman
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5406–5410.
https://doi.org/10.1158/1078-0432.CCR-07-0247
Published: 17 September 2007
View article titled, Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid
Open the PDF for Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid in another window
Journal Articles

Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma

Janet E. Brown, Sue P. Ellis, Paul Silcocks, Aubrey Blumsohn, Sandra A. Gutcher, Clare Radstone, Barry W. Hancock, Matthew Q. Hatton, Robert E. Coleman
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (21): 6480–6486.
https://doi.org/10.1158/1078-0432.CCR-06-1382
Published: 03 November 2006
View article titled, Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma
Open the PDF for Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma in another window
Journal Articles

Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference

Allan Lipton, James R. Berenson, Jean-Jacques Body, Brendan F. Boyce, Oyvind S. Bruland, Michael A. Carducci, Charles S. Cleeland, Denis R. Clohisy, Robert E. Coleman, Richard J. Cook, Theresa A. Guise, Roger N. Pearse, Trevor J. Powles, Michael J. Rogers, G. David Roodman, Matthew R. Smith, Larry J. Suva, Robert L. Vessella, Katherine N. Weilbaecher, Laura King
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6209s–6212s.
https://doi.org/10.1158/1078-0432.CCR-06-1213
Published: 24 October 2006
View article titled, Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference
Open the PDF for Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference in another window
Journal Articles

Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

Robert E. Coleman
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6243s–6249s.
https://doi.org/10.1158/1078-0432.CCR-06-0931
Published: 24 October 2006
View article titled, Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Open the PDF for Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity in another window
Journal Articles

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

Jean-Jacques Body, Thierry Facon, Robert E Coleman, Allan Lipton, Filip Geurs, Michelle Fan, Donna Holloway, Mark C Peterson, Pirow J Bekker
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (4): 1221–1228.
https://doi.org/10.1158/1078-0432.CCR-05-1933
Published: 17 February 2006
View article titled, A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
Open the PDF for A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. in another window